ArticleScientific reports2016

A Dual Target-directed Agent against Interleukin-6 Receptor and Tumor Necrosis Factor α ameliorates experimental arthritis.

Youngkyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.